Clinical Trial

Buspirone for Weak or Absent Esophageal Peristalsis

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2024 (before its estimated September 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, double-blind, placebo-controlled, cross-over clinical trial of buspirone in patients with complaints of dysphagia due to poor esophageal motility. The goal of this clinical trial is to study the effect of buspirone on esophageal motility by performing high resolution impedance manometry (HRiM).
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05629325
Lead Sponsor Universitaire Ziekenhuizen KU Leuven
Conditions Dysphagia, Esophageal
Enrollment 25 participants
Start Date 2021-07-06
Primary Completion 2024-09-30 (estimated)
Study Completion 2024-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-03